Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- Check4 days agoChange DetectedAn NIH grant/contract funding note (2016 U.S. NIH Grant/Contract) was added to the study's identifiers, providing funding attribution for the ALXN1210-PNH-301 trial.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows an updated revision number, moving from v3.6.4 to v3.6.5, indicating a small internal update to the page or site's framework.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing Revision: v3.6.3, indicating a new build/version of the page.SummaryDifference0.0%

- Check61 days agoChange DetectedThe study page now shows Revision: v3.6.3, replacing the previous v3.6.0. This indicates a newer page revision without changes to the study data or eligibility criteria.SummaryDifference0.0%

- Check75 days agoChange DetectedRecruitment status now indicates the study is not enrolling. New guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, the Intervention/Treatment label formatting is updated, and the page revision is noted as v3.6.0.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page now shows a new revision label (v3.5.5) replacing the previous v3.5.4, indicating a minor site update.SummaryDifference0.0%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.